USPTO Grants Sherlock Biosciences Priority Patent for CRISPR-Based Diagnostics
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read MorePosted by Andy Lundin | Feb 21, 2023 | Amplification Technologies |
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read MorePosted by Andy Lundin | Feb 20, 2023 | Company News |
Quest Diagnostics partnered with the regional integrated healthcare system in Pennsylvania to help enhance its diagnostic services.
Read MorePosted by Andy Lundin | Feb 17, 2023 | Covid 19 |
The Rockefeller Foundation has reached an agreement to extend a program that delivers free at-home COVID tests to at-risk communities.
Read MorePosted by Andy Lundin | Feb 16, 2023 | Covid 19, Swabs |
Research led by scientists in Brazil found that the coronavirus that causes COVID can be detected in tears collected by swabbing.
Read MorePosted by Andy Lundin | Feb 15, 2023 | Diagnostic Technologies |
Hurdle and CloudLIMS entered into a strategic partnership that marks the integration between a DaaS platform and a SaaS LIMS provider.
Read More